Anti-ESPL1 monoclonal antibody

Pre-made anti-ESPL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ESPL1/ESPL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0771-Ab-1/ GM-Tg-hg-IP0771-Ab-2Anti-Human ESPL1 monoclonal antibodyHuman
GM-Tg-rg-IP0771-Ab-1/ GM-Tg-rg-IP0771-Ab-2Anti-Rat ESPL1 monoclonal antibodyRat
GM-Tg-mg-IP0771-Ab-1/ GM-Tg-mg-IP0771-Ab-2Anti-Mouse ESPL1 monoclonal antibodyMouse
GM-Tg-cynog-IP0771-Ab-1/ GM-Tg-cynog-IP0771-Ab-2Anti-Cynomolgus/ Rhesus macaque ESPL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0771-Ab-1/ GM-Tg-felg-IP0771-Ab-2Anti-Feline ESPL1 monoclonal antibodyFeline
GM-Tg-cang-IP0771-Ab-1/ GM-Tg-cang-IP0771-Ab-2Anti-Canine ESPL1 monoclonal antibodyCanine
GM-Tg-bovg-IP0771-Ab-1/ GM-Tg-bovg-IP0771-Ab-2Anti-Bovine ESPL1 monoclonal antibodyBovine
GM-Tg-equg-IP0771-Ab-1/ GM-Tg-equg-IP0771-Ab-2Anti-Equine ESPL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0771-Ab-1/ GM-Tg-hg-IP0771-Ab-2; GM-Tg-rg-IP0771-Ab-1/ GM-Tg-rg-IP0771-Ab-2;
GM-Tg-mg-IP0771-Ab-1/ GM-Tg-mg-IP0771-Ab-2; GM-Tg-cynog-IP0771-Ab-1/ GM-Tg-cynog-IP0771-Ab-2;
GM-Tg-felg-IP0771-Ab-1/ GM-Tg-felg-IP0771-Ab-2; GM-Tg-cang-IP0771-Ab-1/ GM-Tg-cang-IP0771-Ab-2;
GM-Tg-bovg-IP0771-Ab-1/ GM-Tg-bovg-IP0771-Ab-2; GM-Tg-equg-IP0771-Ab-1/ GM-Tg-equg-IP0771-Ab-2
Products NameAnti-ESPL1 monoclonal antibody
Formatmab
Target NameESPL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ESPL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0771-Ag-1Recombinant multi-species ESPL1/ ESP1/ SEPA protein


    Target information

    Target IDGM-IP0771
    Target NameESPL1
    Gene ID9700,105988,315330,702136,607879,101084118,506740,100063779
    Gene Symbol and SynonymsCerp,ESP1,ESPL1,PRCE,SEPA,separin,SSE
    Uniprot AccessionQ14674
    Uniprot Entry NameESPL1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000135476
    Target ClassificationTumor-associated antigen (TAA)

    The target: ESPL1, gene name: ESPL1, also named as ESP1, SEPA. Stable cohesion between sister chromatids before anaphase and their timely separation during anaphase are critical for chromosome inheritance. In vertebrates, sister chromatid cohesion is released in 2 steps via distinct mechanisms. The first step involves phosphorylation of STAG1 (MIM 604358) or STAG2 (MIM 300826) in the cohesin complex. The second step involves cleavage of the cohesin subunit SCC1 (RAD21; MIM 606462) by ESPL1, or separase, which initiates the final separation of sister chromatids (Sun et al., 2009 [PubMed 19345191]).[supplied by OMIM, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.